Benzalkonium Chloride (BAC) prices in the U.S. moved higher through March, culminating in a late-month uptick as momentum and trade dynamics kept offers firmer. Mid-month buying activity supported a pronounced rally, while period showed a smaller 0.90% advance, supported by technical buying and importer-cost caution. Weekly movements reflected momentum rather than shocks: 7.65% in the week ending March 13, about 2.20% the following week, and a 0.90% in the week ending March 27. Overall sentiment remained constructive yet balanced, with availability comfortable and plant run-rates normal, supporting a range-bound market under upward pressure. Demand was mixed across end-use sectors: institutional disinfectants provided steady offtake, while personal-care and oilfield segments remained soft with no fresh surges late in the month. Procurement behavior was guarded in mid-March, tempering broader strength. Outlook points to stability with limited upside, aided by inventories, steady plant performance, and freight costs.
